$VICL Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$VICL Up to date company activities and other important information about $VICL

$VICL

DD Notes ~ http://www.ddnotesmaker.com/VICL

##### recent news/filings ~ source: finance.yahoo.com

Tue, 10 Dec 2013 14:49:50 GMT ~ Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
- NORTHBROOK, IL & SAN DIEGO-December 10, 2013-Astellas Pharma Global Development, Inc.,a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), and Vical Incorporated (Nasdaq: VICL) today announced ...
read full: http://www.noodls.com/view/1EB79002E431BBB9C5...27F1045FA8
*********************************************************

Tue, 10 Dec 2013 12:00:00 GMT ~ Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
- NORTHBROOK, Ill. and SAN DIEGO, Dec. 10, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:4503), and Vical Incorporated (VICL) today announced the initiation of a Phase 2 trial of ASP0113 in approximately 140 solid organ transplant (SOT) recipients. The global, randomized, double-blind, placebo-controlled trial is designed to evaluate the efficacy of ASP0113 compared to placebo as measured by the incidence of cytomegalovirus (CMV) viremia in CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. "Following the initiation of our Phase 3 trial of ASP0113 in hematopoietic cell transplant (HCT) recipients in June, we are pleased to expand the ASP0113 program with this Phase 2 trial in SOT recipients," said Bernie Zeiher, Senior Vice President and Global Therapeutic Area Head of Immunology and Infectious Diseases at Astellas Pharma Global Development, Inc. "The unmet medical need to control CMV in transplant recipients remains high."
read full: http://finance.yahoo.com/news/astellas-vical-...00689.html
*********************************************************

Sat, 07 Dec 2013 01:32:00 GMT ~ Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Vical Incorporated
- Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Vical Incorporated concerning possible violations of federal securities laws.
read full: http://finance.yahoo.com/news/law-offices-how...00537.html
*********************************************************

Thu, 05 Dec 2013 23:29:00 GMT ~ SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Vical Incorporated to Contact Brower Piven Before the December 31, 2013 Lead Plaintiff Deadline
- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on beh
read full: http://finance.yahoo.com/news/shareholder-ale...00619.html
*********************************************************

Wed, 27 Nov 2013 22:01:00 GMT ~ SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Vical Incorporated and Certain Officers - VICL
- NEW YORK, Nov. 27, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Vical Incorporated ("Vical" or the "Company") (VICL) and certain of its officers. The class action, filed in United States District Court, Southern District of California, and docketed under 13-cv-02653, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Vical between February 8, 2012 and August 12, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. If you are a shareholder who purchased Vical securities during the Class Period, you have until December 31, 2013 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237.
read full: http://finance.yahoo.com/news/shareholder-ale...00735.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=VICL&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=VICL&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/VICL/company-info
Ticker: $VICL
OTC Market Place: Not Available
CIK code: 0000819050
Company name: Vical Inc.
Company website: http://www.vical.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/VICL/filings
Latest financials: http://www.otcmarkets.com/stock/VICL/financials
Latest news: http://www.otcmarkets.com/stock/VICL/news - http://finance.yahoo.com/q/h?s=VICL+Headlines

Major holdings: http://data.cnbc.com/quotes/VICL/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=VICL+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/VICL.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=VICL

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Vical+Inc.&x=1...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Vical+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.vical.com
Alexa: http://www.alexa.com/siteinfo/http://www.vical.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.vical.com

http://www.pennystocktweets.com/stocks/profile/VICL

##### last known share structure ~ source: otcmarkets.com

Market Value: $118,017,204 a/o Dec 09, 2013
Shares Outstanding: 86,777,356 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01

##### business description ~ source: otcmarkets.com

IC

DD Notes ~ http://www.ddnotesmaker.com/VICL

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protecting Your Family on Halloween: Safety Tips

Updated Category News Views 5

Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
2026 Leica Oskar Barnack Awards Spotlight Global Talent

Updated Category News Views 6

Winners Redefine Photography's Boundaries in 2026 Photographers are like modern-day storytellers, freezing moments in time and weaving visual narratives that provoke thought—or at least that's what the folks behind the Leica Oskar Barnack Award (LOBA) seem to believe. This year's ceremony upped the ante, not just handing out glittering prizes and shiny cameras, but...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 2

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
CellFiber Expands to Philly: Boosting US Biotech Scene

Updated Category News Views 2

CellFiber's Leap into 'Cellicon Valley' Folks, when the biotech winds start blowing, you better have your sails up. CellFiber Co., Ltd., a Tokyo-based innovator, has landed itself a comfy spot in the City of Brotherly Love. We're talking Philadelphia, folks, or, as it's dubbed in certain circles, 'Cellicon Valley.' Now if that's not a name that screams biotech pedigree, I...

Continue Reading
Caitlyn Brazill Takes Helm at Per Scholas: CEO Transition

Updated Category News Views 2

Caitlyn Brazill named CEO, marking a leadership shift Call this one a big baton pass in the world of workforce development. Caitlyn Brazill is stepping into the role of CEO and President at Per Scholas, effective January 1, 2027. She'll be filling the rather large shoes of Plinio Ayala, the man who's been steering the ship since its days in the Bronx, growing it into a...

Continue Reading
Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Updated Category News Views 3

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Continue Reading
AI Visibility: A Game Changer for SEO in 2027?

Updated Category News Views 2

AI Changes the SEO Game Rank Math, the brains behind a trusty WordPress SEO plugin, has thrown a bold prediction at us: AI visibility is set to become a standard SEO metric next year. Gurugram, India, saw this gem of an announcement on October 9, 2026. So, what's ticking here? Consumers, more than ever, are resting on AI-generated answers to make decisions. It's like...

Continue Reading
STRATA Showcases Excimer Laser Success in Dermatology

Updated Category News Views 1

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Continue Reading
HackerOne Finds Cybersecurity Challenges in Exposure Debt

Updated Category News Views 11

Understanding the Implications of 'Exposure Debt' When you hear about 'exposure debt', it's not just tech jargon—it's a core issue hacking at the very safety nets companies rely on. This term, highlighted in HackerOne's latest Security Research Report, marks a stark reality in cybersecurity. The backlog of verified yet unresolved vulnerabilities surged a whopping 131%...

Continue Reading

Top 5 Most Recently Viewed Articles

RM Cyber Launches New Brand to Enhance Cybersecurity Services

Updated Category News Views 112

RM Cyber Transitions from Richey May Cyber to Strengthened Identity Recently, RM Cyber has officially transformed from its previous name, Richey May Cyber, marking a significant change that not only updates its brand image but also enhances the services it provides. This rebranding comes as a strategic move to showcase its specialized skills in cybersecurity and to...

Continue Reading
EnCirca Innovates with Tokenized Domains and Web3 Integration

Updated Category News Views 305

EnCirca Pioneers Tokenized Domains in the Web3 Space EnCirca, a top-tier ICANN-accredited domain registrar, is set to transform the way digital identities are handled online. By partnering with D3's Doma Protocol and MyPublicWallet, EnCirca aims to offer tokenized domain names that integrate seamlessly into the evolving Web3 landscape. This initiative is expected to...

Continue Reading
Empowering Patients: Astellas' Commitment to Advocacy Week

Updated Category News Views 185

Connecting Patients with Advocacy Resources Astellas has announced the second annual Patient Advocacy Organization (PAO) Action Week, a pivotal initiative to empower patients and caregivers. Building on the success of the first event, Astellas' Patient Centricity team continues its commitment to connecting individuals with critical resources provided by patient advocacy...

Continue Reading
Carnival Corporation: Riding High on Strong Demand and Growth

Updated Category News Views 202

Carnival Corporation: Riding High on Strong Demand and Growth Carnival Corporation (NYSE: CCL) is making waves in the market as its stock nears 52-week highs, thanks to a positive shift in investor sentiment. A noteworthy endorsement from Citigroup, which increased its price target to an impressive $37.00, has added fuel to the fire of this rally. This surge in analyst...

Continue Reading
Jack In The Box Faces Decline Post Q4 Earnings Report

Updated Category News Views 151

Understanding Jack In The Box's Earnings Report Jack In The Box, Inc. (NASDAQ: JACK) recently released its fourth-quarter earnings report that surprised many investors. After the closing bell on a Wednesday, the company announced earnings results that did not meet analysts' expectations, causing notable fluctuations in its stock price. Key Financial Highlights The...

Continue Reading